Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Donate
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
When Care(giving) Meet...
Live, educational event for the community around Greenville, SC.
/Events/MSF-Events/2019/One-Time-Events/When-Care(giving)-Meets-Love-(2)
Health and Wellness Grant
The MS Focus Health and Wellness Program offers adaptive exercise and wellness education in safe,...
/Get-Help/MSF-Programs-Grants/Health-and-Wellness-Program
Shop
Privacy
Terms of Use
Site Map
Study: Remyelination candidates target cholesterol-producing enzymes
July 27, 2018
New research offers insight into how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. The study suggests a target for new drugs that may lead to myelin regeneration treatments for people with MS.
In the current study, researchers at Case Western Reserve University School of Medicine demonstrated that miconazole enhanced myelin formation by inhibiting an enzyme used by brain stem cells to produce cholesterol. Subsequent experiments identified more than 20 new drugs that enhance myelin formation by inhibiting closely-related cholesterol-producing enzymes. Drugs identified previously by labs across the world as enhancing new myelin were also found to inhibit these same enzymes.
Results of mouse model studies sometimes do not translate to humans. Clinical candidates based on this work are not expected to enter clinical trials until 2019. However, the authors said the new understanding of myelin repair provides a promising new path toward novel, regenerative MS treatments.
The findings were published in the journal
Nature
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more
Study uncovers potential risks of common MS treatment
Study finds an increased risk of events such as stroke, migraine, and depression, and abnormalities in the blood with taking beta interferon for MS.
Learn more